Nexalin Technology (NXL) Competitors $2.16 -0.18 (-7.69%) Closing price 04:00 PM EasternExtended Trading$2.26 +0.09 (+4.40%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. INFU, TELA, HYPR, ZYXI, LUCD, FONR, EDAP, ICCM, NSPR, and SRTSShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include InfuSystem (INFU), TELA Bio (TELA), Hyperfine (HYPR), Zynex (ZYXI), Lucid Diagnostics (LUCD), FONAR (FONR), Edap Tms (EDAP), IceCure Medical (ICCM), InspireMD (NSPR), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. InfuSystem TELA Bio Hyperfine Zynex Lucid Diagnostics FONAR Edap Tms IceCure Medical InspireMD Sensus Healthcare Nexalin Technology (NASDAQ:NXL) and InfuSystem (NYSE:INFU) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends. Does the media favor NXL or INFU? In the previous week, Nexalin Technology had 1 more articles in the media than InfuSystem. MarketBeat recorded 4 mentions for Nexalin Technology and 3 mentions for InfuSystem. Nexalin Technology's average media sentiment score of 1.00 beat InfuSystem's score of 0.50 indicating that Nexalin Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nexalin Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InfuSystem 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in NXL or INFU? 0.6% of Nexalin Technology shares are owned by institutional investors. Comparatively, 71.1% of InfuSystem shares are owned by institutional investors. 24.0% of Nexalin Technology shares are owned by company insiders. Comparatively, 10.2% of InfuSystem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is NXL or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Nexalin Technology's net margin of -3,407.98%. InfuSystem's return on equity of 2.78% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-3,407.98% -187.59% -167.21% InfuSystem 1.12%2.78%1.41% Does the MarketBeat Community believe in NXL or INFU? InfuSystem received 7 more outperform votes than Nexalin Technology when rated by MarketBeat users. Likewise, 100.00% of users gave InfuSystem an outperform vote while only 66.67% of users gave Nexalin Technology an outperform vote. CompanyUnderperformOutperformNexalin TechnologyOutperform Votes266.67% Underperform Votes133.33% InfuSystemOutperform Votes9100.00% Underperform VotesNo Votes Which has stronger earnings & valuation, NXL or INFU? InfuSystem has higher revenue and earnings than Nexalin Technology. Nexalin Technology is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$168.72K170.32-$4.65M-$0.82-2.63InfuSystem$134.86M0.96$870K$0.1061.50 Do analysts rate NXL or INFU? Nexalin Technology presently has a consensus target price of $5.00, suggesting a potential upside of 131.48%. InfuSystem has a consensus target price of $13.00, suggesting a potential upside of 111.38%. Given Nexalin Technology's higher possible upside, equities research analysts plainly believe Nexalin Technology is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00 Which has more volatility & risk, NXL or INFU? Nexalin Technology has a beta of 4.33, meaning that its share price is 333% more volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. SummaryInfuSystem beats Nexalin Technology on 12 of the 19 factors compared between the two stocks. Remove Ads Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyElectromedical equipment IndustryBusiness SectorNASDAQ ExchangeMarket Cap$28.74M$3.24B$7.56B$8.32BDividend YieldN/A1.61%2.52%4.02%P/E Ratio-3.3715.1130.9019.25Price / Sales170.3241.88150.3894.09Price / CashN/A44.0931.5134.64Price / Book5.023.405.024.46Net Income-$4.65M$89.74M$194.85M$247.07M7 Day Performance-1.82%0.88%1.71%3.05%1 Month Performance-13.60%-8.82%-2.71%-2.85%1 Year Performance331.40%-10.12%6.80%4.63% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology3.2354 of 5 stars$2.16-7.7%$5.00+131.5%+383.5%$28.74M$168,721.00-3.373Upcoming EarningsAnalyst UpgradeNews CoverageGap UpINFUInfuSystem1.913 of 5 stars$5.75+3.6%$13.00+126.1%N/A$120.80M$134.86M95.85410High Trading VolumeTELATELA Bio3.0381 of 5 stars$2.43+3.4%$9.25+280.7%-75.6%$95.71M$68.65M-1.44120Earnings ReportHYPRHyperfine3.2903 of 5 stars$1.28+39.3%$1.60+25.0%-17.8%$93.38M$13.26M-2.25190Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeZYXIZynex3.2887 of 5 stars$2.90-2.4%$10.25+253.4%-79.7%$92.55M$192.35M19.331,100News CoverageHigh Trading VolumeLUCDLucid Diagnostics2.2024 of 5 stars$1.47+5.8%$3.63+146.6%+37.6%$87.23M$4.19M-1.2970Analyst ForecastNews CoverageGap UpHigh Trading VolumeFONRFONAR2.319 of 5 stars$13.98+1.2%N/A-38.4%$86.72M$101.57M12.16480Positive NewsEDAPEdap Tms1.8988 of 5 stars$2.29+1.8%$19.00+729.7%-70.7%$84.97M$63.41M-3.52230Upcoming EarningsGap DownICCMIceCure Medical2.749 of 5 stars$1.52+7.0%$2.70+77.6%+8.4%$84.36M$3.67M-5.2460News CoverageGap UpNSPRInspireMD2.3186 of 5 stars$2.80flat$4.75+69.6%+15.6%$83.13M$7.01M-3.7350SRTSSensus Healthcare2.8394 of 5 stars$4.86+4.5%$13.00+167.5%+27.6%$80.17M$41.81M12.1540 Remove Ads Related Companies and Tools Related Companies InfuSystem Alternatives TELA Bio Alternatives Hyperfine Alternatives Zynex Alternatives Lucid Diagnostics Alternatives FONAR Alternatives Edap Tms Alternatives IceCure Medical Alternatives InspireMD Alternatives Sensus Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXL Stock Free NXL Stock Alerts